Group One Trading
GNMX

Group One Trading’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Group One Trading’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,758
Closed – – 6102
2019
Q4 		$0 Hold
1,758
– – ﹤0.01% 5918
2019
Q3 		$0 Sell
1,758
-100
-5% -$18 ﹤0.01% 5816
2019
Q2 		$0 Hold
1,858
– – ﹤0.01% 5672
2019
Q1 		$0 Hold
1,858
– – ﹤0.01% 5680
2018
Q4 		$1K Buy
1,858
+1,758
+1,758% +$1.96K ﹤0.01% 4775
2018
Q3 		$0 Hold
100
– – ﹤0.01% 5869
2018
Q2 		$0 Hold
100
– – ﹤0.01% 5696
2018
Q1 		$0 Buy
+100
New +$188 ﹤0.01% 5570
2017
Q2 		– Sell
-15,382
Closed -$22.2K – 5312
2017
Q1 		$29K Buy
15,382
+5,129
+50% +$23.2K ﹤0.01% 3715
2016
Q4 		$53K Buy
+10,253
New +$54K ﹤0.01% 3235

Group One Trading's GNMX Position: Q1 2020 in Review

Group One Trading sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 1,758 shares.

Group One Trading first reported a position in GNMX in Q4 2016 and held it in 10 quarters. The position peaked at $53K in Q4 2016. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.

  • Group One Trading reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
  • Group One Trading sold 1,758 Aevi Genomic Medicine Inc shares in Q1 2020.
  • Group One Trading first reported a position in Aevi Genomic Medicine Inc in Q4 2016 and held it in 10 quarters.
  • Group One Trading's Aevi Genomic Medicine Inc position peaked at $53K in Q4 2016.
  • 2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.